These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7482685)

  • 1. Inhibition of trazodone metabolism by thioridazine in humans.
    Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Ishida M; Mihara K; Kondo T; Sugawara K; Fukushima Y
    Ther Drug Monit; 1995 Aug; 17(4):333-5. PubMed ID: 7482685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increases in plasma concentration of m-chlorophenylpiperazine, but not trazodone, with low-dose haloperidol.
    Mihara K; Otani K; Ishida M; Yasui N; Suzuki A; Ohkubo T; Osanai T; Kaneko S; Sugawara K
    Ther Drug Monit; 1997 Feb; 19(1):43-5. PubMed ID: 9029745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patients.
    Otani K; Tybring G; Mihara K; Yasui N; Kaneko S; Ohkubo T; Nagasaki T; Sugawara K
    Eur J Clin Pharmacol; 1998 Jan; 53(5):347-9. PubMed ID: 9516035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carbamazepine coadministration on plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine.
    Otani K; Ishida M; Kaneko S; Mihara K; Ohkubo T; Osanai T; Sugawara K
    Ther Drug Monit; 1996 Apr; 18(2):164-7. PubMed ID: 8721280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of genetic polymorphism of CYP1A2 inducibility on the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patients.
    Mihara K; Kondo T; Suzuki A; Yasui-Furukori N; Ono S; Otani K; Kaneko S
    Pharmacol Toxicol; 2001 May; 88(5):267-70. PubMed ID: 11393588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the CYP2D6 genotype and the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine.
    Mihara K; Otani K; Suzuki A; Yasui N; Nakano H; Meng X; Ohkubo T; Nagasaki T; Kaneko S; Tsuchida S; Sugawara K; Gonzalez FJ
    Psychopharmacology (Berl); 1997 Sep; 133(1):95-8. PubMed ID: 9335086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patients.
    Yasui N; Tybring G; Otani K; Mihara K; Suzuki A; Svensson JO; Kaneko S
    Pharmacogenetics; 1997 Oct; 7(5):369-74. PubMed ID: 9352572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients.
    Mihara K; Yasui-Furukori N; Kondo T; Ishida M; Ono S; Ohkubo T; Osanai T; Sugawara K; Otani K; Kaneko S
    Ther Drug Monit; 2002 Aug; 24(4):563-6. PubMed ID: 12142643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of trazodone and m-chlorophenylpiperazine at steady state can be predicted from those after an initial dose of trazodone.
    Otani K; Mihara K; Yasui N; Ishida M; Kondo T; Tokinaga N; Ohkubo T; Osanai T; Sugawara K; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):239-44. PubMed ID: 9075270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources.
    Rotzinger S; Fang J; Baker GB
    Drug Metab Dispos; 1998 Jun; 26(6):572-5. PubMed ID: 9616194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of various factors on steady state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine.
    Ishida M; Otani K; Kaneko S; Ohkubo T; Osanai T; Yasui N; Mihara K; Higuchi H; Sugawara K
    Int Clin Psychopharmacol; 1995 Sep; 10(3):143-6. PubMed ID: 8675966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of novel reactive metabolites of trazodone: evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine.
    Wen B; Ma L; Rodrigues AD; Zhu M
    Drug Metab Dispos; 2008 May; 36(5):841-50. PubMed ID: 18238857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose proportionality of once-daily trazodone extended-release caplets under fasting conditions.
    Karhu D; Groenewoud G; Potgieter MA; Mould DR
    J Clin Pharmacol; 2010 Dec; 50(12):1438-49. PubMed ID: 20173086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trazodone generates m-CPP: in 2008 risks from m-CPP might outweigh benefits of trazodone.
    Kast RE
    World J Biol Psychiatry; 2009; 10(4 Pt 2):682-5. PubMed ID: 19384678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
    Maes M; Westenberg H; Vandoolaeghe E; Demedts P; Wauters A; Neels H; Meltzer HY
    J Clin Psychopharmacol; 1997 Oct; 17(5):358-64. PubMed ID: 9315986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine.
    Suzuki A; Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Kaneko S; Inoue Y; Shibata M; Ikeda K
    Ther Drug Monit; 1997 Jun; 19(3):261-4. PubMed ID: 9200764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextromethorphan and mephenytoin phenotyping of patients treated with thioridazine or amitriptyline.
    Baumann P; Meyer JW; Amey M; Baettig D; Bryois C; Jonzier-Perey M; Koeb L; Monney C; Woggon B
    Ther Drug Monit; 1992 Feb; 14(1):1-8. PubMed ID: 1546384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic determination of trazodone and 1-m-chlorophenylpiperazine with ultraviolet and electrochemical detector.
    Ohkubo T; Osanai T; Sugawara K; Ishida M; Otani K; Mihara K; Yasui N
    J Pharm Pharmacol; 1995 Apr; 47(4):340-4. PubMed ID: 7791034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trazodone treatment increases plasma prolactin concentrations in depressed patients.
    Otani K; Yasui N; Kaneko S; Ishida M; Ohkubo T; Osanai T; Sugawara K; Fukushima Y
    Int Clin Psychopharmacol; 1995 Jun; 10(2):115-7. PubMed ID: 7673654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of trazodone and its metabolite, 1-m-chlorophenyl-piperazine, in human plasma and red blood cell samples by HPLC.
    Vatassery GT; Holden LA; Hazel DK; Dysken MW
    Clin Biochem; 1997 Mar; 30(2):149-53. PubMed ID: 9127697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.